Evidence map›Paper›PMID 24527313›Full record

ReviewAdvances in wound care2012

The Beginning of the End: CXCR3 Signaling in Late-Stage Wound Healing.

Arthur C Huen, Alan Wells

Open access · greenAbstract readReview
In one paragraph

Review in Advances in wound care, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. CCL2 and CXCL10 are associated with poor outcome after intracerebral hemorrhage.Annals of clinical and translational neurology · 2018
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. CXCR3 in carcinoma progression.Histology and histopathology · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Arthur C HuenDepartment of Dermatology, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania.
Alan WellsDepartment of Pathology, University of Pittsburgh Medical Center , Pittsburgh, Pennsylvania. ; Department of Pathology, Veterans Administration Medical Center , Pittsburgh, Pennsylvania.
University of Pittsburgh Medical Center · US

Funding

Dermal-Epidermal Communication during Wound HealingR01GM063569 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WELLS, ALAN · 2003 to 2018
$3.7M
Cutaneous wound remodeling by re-differentiating keratinocytes expressing CXCR3 lK08GM095917 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HUEN, ARTHUR · 2011 to 2015
$602k
NIGMS NIH HHS K08 GM095917NIGMS NIH HHS R01 GM063569
6 · The paper itself

Abstract

backgroundPrior to 2009, research regarding the role of CXC receptor 3 (CXCR3) in cutaneous biology was primarily in the context of inflammatory reactions. Foundational research performed at that time demonstrated that, in addition to recruited inflammatory cells, cellular components of the skin, keratinocytes, fibroblasts, and endothelial cells, also express CXCR3 and are capable of expressing CXCR3 ligands, specifically CXC ligand 10 (CXCL10) and CXCL11. Surprisingly, THE PROBLEM: These findings demonstrate the role of CXCR3 signaling in the latter stages of wounding healing and opened a new avenue of investigation into the molecular and cellular mechanisms of coordinating the events of cutaneous tissue regeneration. BASIC SCIENCE ADVANCES: More recent investigation highlights the role of CXCR3 signaling in the dramatic vascular pruning events after the proliferative stage of wound healing and its importance in guiding remodeling of dermal collagen during cicatrix formation.

conclusionCXCR3 signaling plays a strong role in coordinating the actions of several cell types during cutaneous wound healing. The disruption of this signaling pathway results in delayed return to homeostasis and dystrophic scarring.

Identifiers

PMID24527313
PMCPMC3623597
OpenAlexW2077288077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.